EPITHELIOID HEMANGIOENDOTHELIOMA
Clinical trials for EPITHELIOID HEMANGIOENDOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new EPITHELIOID HEMANGIOENDOTHELIOMA trials appear
Sign up with your email to follow new studies for EPITHELIOID HEMANGIOENDOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat sarcomas
Disease control OngoingThis study tests whether combining two drugs, lenvatinib and pembrolizumab, can safely shrink or control advanced soft tissue sarcomas that have spread or can't be removed by surgery. About 52 adults with specific sarcoma types will receive the combination. The goal is to measure…
Matched conditions: EPITHELIOID HEMANGIOENDOTHELIOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a chemo drug tame rare vascular tumors?
Disease control OngoingThis small pilot study tested the drug eribulin (Halaven) in 13 people with two rare cancers of blood vessels: angiosarcoma and epithelioid hemangioendothelioma (EHE). The goal was to see if the drug could shrink tumors or stop them from growing. Participants had already tried at…
Matched conditions: EPITHELIOID HEMANGIOENDOTHELIOMA
Phase: PHASE2 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC